BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 28814568)

  • 1. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis.
    Arora K; Bal M; Shih A; Moy A; Zukerberg L; Brown I; Liu X; Kelly P; Oliva E; Mullen J; Ahn S; Kim KM; Deshpande V
    J Clin Pathol; 2018 Mar; 71(3):221-227. PubMed ID: 28814568
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for hepatocellular differentiation in alpha-fetoprotein-negative gastric adenocarcinoma with hepatoid morphology: a study with in situ hybridisation for albumin mRNA.
    Supriatna Y; Kishimoto T; Uno T; Nagai Y; Ishikura H
    Pathology; 2005 Jun; 37(3):211-5. PubMed ID: 16175893
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1.
    Zhao M; Sun L; Lai JZ; Shi H; Mei K; He X; Jin X; Lai J; Cao D
    Pathol Res Pract; 2018 Oct; 214(10):1707-1712. PubMed ID: 30196987
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arginase-1 is frequently positive in hepatoid adenocarcinomas.
    Chandan VS; Shah SS; Torbenson MS; Wu TT
    Hum Pathol; 2016 Sep; 55():11-6. PubMed ID: 27137985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma.
    Osada M; Aishima S; Hirahashi M; Takizawa N; Takahashi S; Nakamura K; Tanaka M; Maehara Y; Takayanagi R; Oda Y
    Hum Pathol; 2014 Jun; 45(6):1243-50. PubMed ID: 24767858
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SALL4 represents fetal gut differentiation of gastric cancer, and is diagnostically useful in distinguishing hepatoid gastric carcinoma from hepatocellular carcinoma.
    Ushiku T; Shinozaki A; Shibahara J; Iwasaki Y; Tateishi Y; Funata N; Fukayama M
    Am J Surg Pathol; 2010 Apr; 34(4):533-40. PubMed ID: 20182341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preliminary study on the clinical and pathological relevance of gastric hepatoid adenocarcinoma.
    Gao YB; Zhang DF; Jin XL; Xiao JC
    J Dig Dis; 2007 Feb; 8(1):23-8. PubMed ID: 17261131
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatoid adenocarcinoma with liver metastasis mimicking hepatocellular carcinoma: an immunohistochemical and molecular study of eight cases.
    Terracciano LM; Glatz K; Mhawech P; Vasei M; Lehmann FS; Vecchione R; Tornillo L
    Am J Surg Pathol; 2003 Oct; 27(10):1302-12. PubMed ID: 14508391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metastatic gastrointestinal hepatoid adenocarcinoma of the liver: a high-grade carcinoma that is easily confused with primary hepatocellular carcinoma].
    Lou KX; Fu Y; Wu HY; Wang T; Kwasi ASD; Fan XS
    Zhonghua Bing Li Xue Za Zhi; 2020 Jul; 49(7):710-714. PubMed ID: 32610383
    [No Abstract]   [Full Text] [Related]  

  • 10. Albumin gene expression in adenocarcinomas with hepatoid differentiation.
    Foschini MP; Baccarini P; Dal Monte PR; Sinard J; Eusebi V; Rosai J
    Virchows Arch; 1998 Dec; 433(6):537-41. PubMed ID: 9870687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatoid adenocarcinoma of the stomach. A clinicopathologic and immunohistochemical analysis.
    Nagai E; Ueyama T; Yao T; Tsuneyoshi M
    Cancer; 1993 Sep; 72(6):1827-35. PubMed ID: 7689918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatoid adenocarcinoma of the lung: report of five cases and review of the literature.
    Haninger DM; Kloecker GH; Bousamra Ii M; Nowacki MR; Slone SP
    Mod Pathol; 2014 Apr; 27(4):535-42. PubMed ID: 24030743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. α-Fetoprotein-producing gastric carcinoma and combined hepatocellular and cholangiocarcinoma show similar morphology but different histogenesis with respect to SALL4 expression.
    Ikeda H; Sato Y; Yoneda N; Harada K; Sasaki M; Kitamura S; Sudo Y; Ooi A; Nakanuma Y
    Hum Pathol; 2012 Nov; 43(11):1955-63. PubMed ID: 22516245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of Markers of Hepatocellular Differentiation in Pancreatic Acinar Cell Neoplasms:  A Potential Diagnostic Pitfall.
    Askan G; Deshpande V; Klimstra DS; Adsay V; Sigel C; Shia J; Basturk O
    Am J Clin Pathol; 2016 Aug; 146(2):163-9. PubMed ID: 27425386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carcinoma of the stomach with hepatocyte differentiation (hepatoid adenocarcinoma).
    Roberts CC; Colby TV; Batts KP
    Mayo Clin Proc; 1997 Dec; 72(12):1154-60. PubMed ID: 9413299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathologic and immunohistochemical characteristics of gastric adenocarcinoma with enteroblastic differentiation: a study of 29 cases.
    Murakami T; Yao T; Mitomi H; Morimoto T; Ueyama H; Matsumoto K; Saito T; Osada T; Nagahara A; Watanabe S
    Gastric Cancer; 2016 Apr; 19(2):498-507. PubMed ID: 25893262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of arginase-1, glypican-3, hepatocyte paraffin antigen 1 and alpha-fetoprotein in diagnosis and differential diagnosis of liver tumors].
    Li J; Wei L
    Zhonghua Bing Li Xue Za Zhi; 2014 Apr; 43(4):246-50. PubMed ID: 24915815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HER2 is frequently overexpressed in hepatoid adenocarcinoma and gastric carcinoma with enteroblastic differentiation: a comparison of 35 cases to 334 gastric carcinomas of other histological types.
    Fujimoto M; Matsuzaki I; Nishino M; Iwahashi Y; Warigaya K; Kojima F; Ono K; Murata SI
    J Clin Pathol; 2018 Jul; 71(7):600-607. PubMed ID: 29305518
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrolamellar carcinoma of the liver exhibits immunohistochemical evidence of both hepatocyte and bile duct differentiation.
    Ward SC; Huang J; Tickoo SK; Thung SN; Ladanyi M; Klimstra DS
    Mod Pathol; 2010 Sep; 23(9):1180-90. PubMed ID: 20495535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.